Transcatheter Arterial Chemo Infusion (TACI) for Buccal Squamous Cell Carcinoma: A Case Report
DOI:
https://doi.org/10.35790/msj.v8i1.64479Keywords:
buccal squamous cell carcinoma; transcatheter arterial chemo infusionAbstract
Abstract: Buccal squamous cell carcinoma (BSCC) is a rare and aggressive malignancy of the oral cavity. Traditional treatment modalities include surgery, radiotherapy, and chemotherapy. Transcatheter arterial chemo infusion (TACI) is a minimally invasive procedure that delivers chemotherapeutic agents directly to the tumor site, potentially improving local control and reducing systemic toxicity. We reported an 84-year-old male presented with one-year history of a progressively enlarging mass and ulceration on the left cheek, accompanied by pain and bleeding. A previous biopsy and excision in 2023 were followed by tumor recurrence three months prior to this admission. Notable history included extensive sun exposure without protection. Physical examination revealed a 12x8 cm friable mass with necrotic tissue. Histopathology confirmed squamous cell carcinoma. The patient underwent TACI with docetaxel, cisplatin, and 5-FU, resulting in significant tumor reduction and symptomatic improvement. Follow-up imaging and histopathological evaluation confirmed a positive response to the treatment. The patient experienced minimal side effects and maintained a good quality of life. In conclusion, TACI presents a promising alternative for the management of BSCC, particularly in patients who are not suitable candidates for surgery. This case highlights the potential of TACI as an effective and minimally invasive treatment option for BSCC, warranting further investigation in larger clinical trials.
Keywords: buccal squamous cell carcinoma; transcatheter arterial chemo infusion
References
1. Khan SM, Syed TT, Syed RT. Squamous cell carcinoma affecting oral mucosa: a clinical case report. IOSR J Dent Med Sci. 2023;22(8):25-8. Doi:10.9790/0853-2208252528
2. Liu X, Wang Z, Chen Z, Liu L, Ma L, Dong L, et al. Efficacy and safety of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion in hepatocellular carcinoma: A systematic review and meta-analysis. Oncol Res2018;26(2):231–9.
3. Pednekar M. Carcinoma buccal mucosa with absent uvula: a case report. IOSR J Dent Med Sci. 2017;16(4):133-5. Doi:10.9790/0853-1604133135
4. Tryfonidis K, Senkus E, Cardoso MJ, Cardoso F. Management of locally advanced breast cancer-perspectives and future directions. Nat Rev Clin Oncol. 2015;12(3):147-62. Doi:10.1038/nrclinonc.2015.12
5. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol. 1954;30(5):969-77. Available from: https://pubmed.ncbi.nlm.nih.gov/13197542/
6. Poedjomartono B, Pramiadi. The role of transcatheter arterial chemoinfusion (TACI) in unresectable adenocarcinoma colorectal: a case report. J Med Sci. 2019;51(3):270-81. Doi: https://doi.org/10.19106/ JMedSci005103201910
7. Reddy RK, Dasara MR. Oral squamous cell carcinoma of buccal mucosa in a young patient: a case report. J Adv Med Dent Sci Res. 2015;3(1):165-8. Doi:10.21276/jamdsr.2015.3.1.35
8. Sun MH, Yi WD, Shen L, Zhou L, Lu JX. Transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: a case report. World J Clin Cases. 2022;10(21):7467-73. Doi: 10.12998/wjcc.v10.i21.7467
9. Poedjomartono B, Banung AA, Frinces FS, Indrarto EYY, Faiz A. Transcatheter arterial chemo infusion (TACI) for squamous cell carcinoma of the tongue: a case report. Indonesian J cancer. 2024;18(2):203-8. Doi : http://dx.doi.org/10.33371/ijoc.v18i2.1043
10. Nishikawa H, Osaki Y, Kita R, Kimura T, Ohara Y, Takeda H, et al. Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma. Anticancer Res. 2014;34(12):6877-86. Doi: https://doi.org/10.3892/ or.2013.2845
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Diska Astarini, Christian Manginstar, Marselus Merung
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
COPYRIGHT
Authors who publish with this journal agree to the following terms:
Authors hold their copyright and grant this journal the privilege of first publication, with the work simultaneously licensed under a Creative Commons Attribution License that permits others to impart the work with an acknowledgment of the work's origin and initial publication by this journal.
Authors can enter into separate or additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (for example, post it to an institutional repository or publish it in a book), with an acknowledgment of its underlying publication in this journal.
Authors are permitted and encouraged to post their work online (for example, in institutional repositories or on their website) as it can lead to productive exchanges, as well as earlier and greater citation of the published work (See The Effect of Open Access).
